GET THE APP
Osteosarcoma High Impact Factor Journals | Open Access Journals
Cancer Science & Therapy

Cancer Science & Therapy

ISSN: 1948-5956

Open Access
Spanish Chinese Russian German French Japanese Portuguese Hindi Telugu Tamil
Submit Manuscript arrow_forward arrow_forward ..

Osteosarcoma High Impact Factor Journals

Osteosarcoma, the second most common primary malignant bone tumor, is usually found in long bones 42% occupying the femur, 19% in tibia, and 10% in the humerus. About 8% of all cases occur in the skull and jaw and other 8% in the pelvis . Osteosarcoma of jaw is rare, aggressive malignant neoplasm which is characterized by formation of osteoid tissue. Jaw osteosarcomas usually presents in 3rd and 4th decade of life. High-impact journals are those considered to be highly influential in their respective fields. The impact factor of journal provides quantitative assessment tool for grading, evaluating, sorting and comparing journals of comparable kind. It reflects the typical number of citations to recent articles published in science and science journals during a particular year or period, and is usually used as a proxy for the relative importance of a journal within its field. It is first devised by Eugene Garfield, the founding father of the Institute for Scientific Information. The impact factor of a journal is evaluated by dividing the amount of current year citations to the source items published therein journal during the previous two years.

High Impact List of Articles
Conference Proceedings

Relevant Topics in Medical Sciences

Awards & Nominations

50+ Million Readerbase

Journal Highlights

Google Scholar citation report
Citations: 5332

Cancer Science & Therapy received 5332 citations as per Google Scholar report

Citation image
Cancer Science & Therapy peer review process verified at publons
Publon image

Indexed In

Related Links

PMC/PubMed Indexed Articles
Blocking PD1/PDL1 Interactions Together with MLN4924 Therapy is a Potential Strategy for Glioma Treatment
Advances in NKT cell Immunotherapy for Glioblastoma.

View More »

 

Open Access Journals

arrow_upward arrow_upward